AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial (vol 19, 649, 2018)



Lawrence, David S, Youssouf, Nabila, Molloy, Sile F, Alanio, Alexandre, Alufandika, Melanie, Boulware, David R, Boyer-Chammard, Timothee, Chen, Tao ORCID: 0000-0002-5489-6450, Dromer, Francoise, Hlupeni, Admire
et al (show 19 more authors) (2019) AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial (vol 19, 649, 2018). TRIALS, 20 (1). 48-.

[img] Text
13063_2018_Article_3026.pdf - Published version

Download (1MB)

Abstract

Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected.

Item Type: Article
Uncontrolled Keywords: 6.1 Pharmaceuticals, 6 Evaluation of treatments and therapeutic interventions
Depositing User: Symplectic Admin
Date Deposited: 25 Feb 2019 16:40
Last Modified: 15 Mar 2024 00:26
DOI: 10.1186/s13063-018-3155-9
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3033286